Clevudine: a promising therapy for the treatment of chronic hepatitis B.

@article{Asselah2008ClevudineAP,
  title={Clevudine: a promising therapy for the treatment of chronic hepatitis B.},
  author={Tarik Asselah and Olivier Lada and Rami Moucari and Patrick Marcellin},
  journal={Expert opinion on investigational drugs},
  year={2008},
  volume={17 12},
  pages={1963-74}
}
Chronic hepatitis B virus (HBV) infection, affecting approximately 350 million people worldwide, is associated with significant morbidity and mortality. In the past 10 years, hepatitis B therapy research has led to a multitude of available antiviral therapies: IFN-alpha, pegylated IFN-alpha(2a), lamivudine, adefovir, entecavir, telbivudine and tenofovir. To further improve reductions in viral load and resistance profiles, development of new HBV therapeutic strategies has been an important focus… CONTINUE READING